Brief: ANTHERA PHARMA REPORTS Q3 LOSS PER SHARE $0.58
06/11/2017 13:30
Nov 6 (Reuters) - Anthera Pharmaceuticals Inc ANTH.O :
* ANTHERA PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND
REPORTS
2017 THIRD QUARTER FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.58
* ENDED Q3 OF 2017 WITH CASH AND CASH EQUIVALENTS TOTALING
$6.1
MILLION, COMPARED TO $20.8 MILLION AS OF DECEMBER 31, 2016
Source text for Eikon: ID:nGNXOGQRIa
Further company coverage: ANTH.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Anthera Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
Brief: Anthera Pharma's Board Approves Personnel Reorganization Plan
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Netflix, BlueLinx, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, BlueLinx, Orexigen, Micron
U.S. STOCKS ON THE MOVE-Anthera, Oclaro, Intel, Broadcom, Orexigen, Goldman